Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) FCF Margin (2016 - 2025)

Historic FCF Margin for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to 32.26%.

  • Immucell's FCF Margin fell 201600.0% to 32.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.58%, marking a year-over-year increase of 62700.0%. This contributed to the annual value of 0.41% for FY2024, which is 371800.0% up from last year.
  • As of Q3 2025, Immucell's FCF Margin stood at 32.26%, which was down 201600.0% from 22.44% recorded in Q2 2025.
  • Over the past 5 years, Immucell's FCF Margin peaked at 22.44% during Q2 2025, and registered a low of 99.93% during Q1 2023.
  • Its 5-year average for FCF Margin is 17.81%, with a median of 10.1% in 2021.
  • As far as peak fluctuations go, Immucell's FCF Margin tumbled by -971100bps in 2023, and later skyrocketed by 1047300bps in 2024.
  • Over the past 5 years, Immucell's FCF Margin (Quarter) stood at 2.14% in 2021, then plummeted by -3225bps to 71.29% in 2022, then surged by 76bps to 17.2% in 2023, then skyrocketed by 85bps to 2.57% in 2024, then tumbled by -1155bps to 32.26% in 2025.
  • Its last three reported values are 32.26% in Q3 2025, 22.44% for Q2 2025, and 15.43% during Q1 2025.